Posted by Clinical Lab Products | Aug 24, 2009 | Miscellaneous |
Epocal Inc announces that it has received FDA clearance to market its new glucose test on the epoc Blood Analysis System. Glucose measurements are used for the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus and idiopathic hypoglycemia, and of pancreatic islet cell tumors.
Read MorePosted by Clinical Lab Products | Jul 30, 2009 | Miscellaneous |
Michael Cobble, MD, director of Canyons Medical Center in Sandy, Utah, has been appointed as Chief Medical Officer of Atherotech Inc.
Read MorePosted by Clinical Lab Products | Jul 8, 2009 | Miscellaneous |
TRANSCEND: Nine Steps to Living Well Forever (Rodale, 2009) by anti-aging authority Terry Grossman, MD, and futurist Ray Kurzweil, identifies the VAP advanced lipid profile as one of the future technologies in cardiovascular risk assessment.
Read MorePosted by Clinical Lab Products | Jun 23, 2009 | Miscellaneous |
HemoCue Inc announced that it has signed an agreement with Medical Automation Systems Inc (MAS) for the development of a RALS-Plus module for the HemoCue 201 DM analyzer whole blood systems for hemoglobin and glucose point-of-care measurement.
Read MorePosted by Clinical Lab Products | Jun 4, 2009 | Diabetes & Metabolic Diseases, POC Instruments |
HemoCue AB, a subsidiary of Quest Diagnostics Inc, announces that it has signed an agreement with MEC Dynamics Corp (MEC) for the exclusive distribution of the Avie(TM) A1c point-of-care test in the US and Europe.
Read More